ArticleJournal of the Endocrine Society2019
Anti-Müllerian Hormone Levels and Cardiometabolic Disturbances by Weight Status Among Men in the 1999 to 2004 National Health and Nutrition Examination Survey.
Article in Journal of the Endocrine Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 15 citations in OpenAlex.
- Serum Inhibin B and Cardiometabolic Profile in Adult Men: A Cross-Sectional Study.Metabolites · 2026Article
- Cardiometabolic markers and serum amh levels in PCOS: can AMH serve as a surrogate cardiometabolic markeR?BMC women's health · 2025Article
- Reduced anti-Müllerian hormone levels in males with inherited bone marrow failure syndromes.Endocrine connections · 2024Article
- AMH in Males: Effects of Body Size and Composition on Serum AMH Levels.Journal of clinical medicine · 2023Article
- Anti-Müllerian hormone concentration is associated with central adiposity and reproductive hormones in expectant fathers.Clinical endocrinology · 2022Article
- Anti-mullerian hormone attenuates insulin resistance and systemic inflammation in old obese C57BL/6 male mice.Journal of diabetes and metabolic disorders · 2021Article
- Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.Circulation · 2021Article
- Anti-Müllerian hormone levels and risk of type 2 diabetes in women.Diabetologia · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
contextSerum anti-Müllerian hormone level (AMH) and body mass index may be jointly associated with cardiometabolic risk.
objectivesExamine the contribution of AMH to cardiometabolic disturbances by weight status among US adult men.
designCross-sectional analysis using data from the 1999 to 2004 waves of the National Health and Nutrition Examination Survey.
settingMultistage probability sampling of the noninstitutionalized US population.
participantsUS men aged ≥18 years. Final analytic sample sizes ranged from 517 to 1063 participants. MAIN OUTCOME AND EXPOSURE MEASURES: Cardiometabolic disturbances (metabolic syndrome and its components, insulin resistance, diabetes, and chronic inflammation) and AMH were obtained from trained staff and nurses in a mobile examination center or during in-home visits.
resultsAMH was directly associated with insulin resistance among obese men [OR 1.08 (95% CI 1.00, 1.15);
conclusionsAMH was associated with specific cardiometabolic risk factors, including WC, diabetes status, and insulin resistance, in overweight and obese US men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.